Meridian Bioscience reported $0 in Ordinary Share Capital for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ordinary Share Capital Change
Accelerate Diagnostics AXDX:US 65K 4K
Atrion ATRI:US 342K 0
Cerulean Pharma CERU:US $ 0.01M 0M
Cerus CERS:US $ 0.17M 0M
Genmark Diagnostics GNMK:US $ 0.01M 0M
Luminex LMNX:US $ 0.05M 0M
Myriad Genetics MYGN:US $ 0.8M 0M
Neogen NEOG:US $ 17.2M 0M
Oxford Immunotec Global OXFD:US $ 0.27M 0M
Quidel QDEL:US $ 0.04M 0M
Staar Surgical STAA:US $ 0.48M 0M
Trinity Biotech TRIB:US $ 1.21M 0M